SEC Form 4 · accession 0001645627-18-000081
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Dec 21, 2018
Accepted (ET)
Dec 31, 2018 · 12:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2018 | P | 2,000 | $0.0196 | A | 26,369,898 | D | |
| Common Stock | Dec 21, 2018 | P | 3,000 | $0.0199 | A | 26,372,898 | D | |
| Common Stock | Dec 21, 2018 | P | 3,000 | $0.0194 | A | 26,375,898 | D | |
| Common Stock | Dec 21, 2018 | P | 10,000 | $0.018 | A | 26,385,898 | D | |
| Common Stock | Dec 21, 2018 | P | 10,000 | $0.0189 | A | 26,395,898 | D | |
| Common Stock | Dec 21, 2018 | P | 10,000 | $0.0189 | A | 26,405,898 | D | |
| Common Stock | Dec 21, 2018 | P | 5,000 | $0.0189 | A | 26,410,898 | D | |
| Common Stock | Dec 21, 2018 | P | 5,000 | $0.0182 | A | 26,415,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0182 | A | 26,416,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0185 | A | 26,417,898 | D | |
| Common Stock | Dec 21, 2018 | P | 5,000 | $0.0184 | A | 26,422,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0184 | A | 26,423,898 | D | |
| Common Stock | Dec 21, 2018 | P | 10,000 | $0.0182 | A | 26,433,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0185 | A | 26,434,898 | D | |
| Common Stock | Dec 21, 2018 | P | 5,000 | $0.0182 | A | 26,439,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0182 | A | 26,440,898 | D | |
| Common Stock | Dec 21, 2018 | P | 2,000 | $0.0185 | A | 26,442,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0182 | A | 26,443,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0185 | A | 26,444,898 | D | |
| Common Stock | Dec 21, 2018 | P | 5,000 | $0.0185 | A | 26,449,898 | D | |
| Common Stock | Dec 21, 2018 | P | 20,000 | $0.0182 | A | 26,469,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0178 | A | 26,470,898 | D | |
| Common Stock | Dec 21, 2018 | P | 2,000 | $0.0182 | A | 26,472,898 | D | |
| Common Stock | Dec 21, 2018 | P | 3,000 | $0.0182 | A | 26,475,898 | D | |
| Common Stock | Dec 21, 2018 | P | 2,000 | $0.0182 | A | 26,477,898 | D | |
| Common Stock | Dec 21, 2018 | P | 10,000 | $0.0182 | A | 26,487,898 | D | |
| Common Stock | Dec 21, 2018 | P | 5,000 | $0.0182 | A | 26,492,898 | D | |
| Common Stock | Dec 21, 2018 | P | 2,000 | $0.0182 | A | 26,494,898 | D | |
| Common Stock | Dec 21, 2018 | P | 10,000 | $0.0182 | A | 26,504,898 | D | |
| Common Stock | Dec 21, 2018 | P | 1,000 | $0.0185 | A | 26,505,898 | D |
Table II — derivative securities
No Table II lines on this filing.